|
SAKAI Shuji
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Position Professor and Division head |
|
| Article types | Other |
| Language | English |
| Peer review | Non peer reviewed |
| Title | 11C-methionine PET/CT findings in benign brain disease. |
| Journal | Formal name：Japanese journal of radiology Abbreviation：Jpn J Radiol ISSN code：(1867-108X)1867-1071(Linking) |
| Domestic / Foregin | Domestic |
| Volume, Issue, Page | 35(6),pp.279-288 |
| Author and coauthor | Nakajima Reiko, Kimura Ken, abe Koichiro, Sakai Shuji, 坂井 修二 |
| Authorship | Last author |
| Publication date | 2017/06 |
| Summary | 11C-methionine (MET) is one of the most commonly used positron emission tomography (PET) tracers for evaluation of malignant brain tumor, with MET-PET being a sensitive technique for visualization of primary and recurrent malignant brain tumors. However, previous reports have demonstrated MET uptake in lesions associated with benign brain diseases. These diseases usually show an increase in MET uptake similar to that of malignant tumors. This pitfall in MET-PET image interpretation is important not only for nuclear medicine professionals, but also for radiologists. In this review, we demonstrate the imaging characteristics of MET uptake in benign brain disease, and recommend physician interpretation of imaging findings and disease characteristics for optimal patient management. Benign uptake must be identified to prevent misdiagnosis and unnecessary surgical operations. |
| DOI | 10.1007/s11604-017-0638-7 |
| PMID | 28421396 |